Human brucellosis in Macedonia-10 years of clinical experience in endemic region

Croatian Medical Journal

Volumn 51, Issue 3, 2010, Pages 327-336

  Bosilkovski, Mile ^a   Krteva, Ljiljana ^a   Dimzova, Marija ^a   Vidinic, Ivan ^a   Sopova, Zaklina ^a   Spasovska, Katerina ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; RIFAMPICIN; BACTERIUM ANTIBODY; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; BACTERIAL TRANSMISSION; BRUCELLOSIS; CHILD; CLINICAL FEATURE; ENDEMIC DISEASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEPATOMEGALY; HUMAN; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SWEATING; ANTIBODY DETECTION; ANTIBODY TITER; BRUCELLA; CORTICOSTEROID THERAPY; DRUG TREATMENT FAILURE; FAMILY HISTORY; FOLLOW UP; NONHUMAN; OCCUPATIONAL EXPOSURE; RELAPSE; TREATMENT DURATION; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; ARTHRALGIA; BRUCELLOSIS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ENDEMIC DISEASES; FEMALE; FEVER; HUMANS; INFANT; MACEDONIA (REPUBLIC); MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SWEATING; TIME FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT; ZOONOSES;

EID: 77955938372     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2010.51.327     Document Type: Article

References (87)

1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325-36. Medline:15930423 doi:10.1056/ NEJMra050570
2. Mantovani A. General epidemiological aspects of major zoonoses in the Mediterranean Region. Proceedings of the MZCP/Workshop on Zoonoses Surveillance and Control in the Mediterranean Region; 1998 Mar 30-31; Cephalonia Island, Greece. Athens: WHO Mediterranean Zoonoses Control Centre; 1998. p. 4-7.
3. Mousa AR, Elhag KM, Khogali M, Marafie AA. The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis. 1988;10:211-7. Medline:3353631
4. Bosilkovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis. 2007;11:342-7. Medline:17241808 doi:10.1016/j.ijid.2006.10.002
5. Madkour MM. Historical aspect of brucellosis. In: Madkuor MM, editor. Brucellosis. Cambridge (UK): Butterworths, University Press; 1989. p. 1-10.
6. Hughes ML. Mediterranean, Malta or undulant fever. London: Macmillan and Co; 1897.
7. Spink WW. The nature of brucellosis. Minneapolis (MN): University of Minnesota Press; 1956.
8. Bosilkovski M, Dimzova M, Grozdanovski K. Natural history of brucellosis in an endemic region in different time periods. Acta Clin Croat. 2009;48:41-6. Medline:19623871
9. Kerr WR, McCaughey WJ, Coghlan JD, Payne DJ, Quaife RA, Robertson L, et al. Techniques and interpretations in the serological diagnosis of brucellosis in man. J Med Microbiol. 1968;1:181-93. Medline:4989595 doi:10.1099/00222615-1- 2-181
10. Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. 2nd ed. Geneva (Switzerland): WHO Monograph Series; 1975.
11. Serra J, Velasco J, Godoy P, Mendoza J. Can the Brucellacapt test be substituted for the Coombs test in the diagnosis of human brucellosis? [in Spanish]. Enferm Infecc Microbiol Clin. 2001;19:202-5. Medline:11446907
12. Bosilkovski M, Krteva L, Caparoska S, Dimzova M. Osteoarticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J. 2004;45:727-33. Medline:15578807
13. Dokuzoguz B, Ergonul O, Baykam N, Esener H, Kilic S, Celikbac A, et al. Characteristics of B. melitensis versus B. abortus bacteraemias. J Infect. 2005;50:41-5. Medline:15603839
14. Aygen B, Doganay M, Sumerkan B, Yildiz O, Kayaba U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect. 2002;32:485-493 doi:10.1016/S0399- 077X(02)00403-1
15. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect. 2004;132:1109-14. Medline:15635968 doi:10.1017/S0950268804002833
16. Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E. Brucellosis and the respiratory system. Clin Infect Dis. 2003;37:e95-9. Medline:13130417 doi:10.1086/378125
17. Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine. 2005;84:174-87. Medline:15879907 doi:10.1097/01.md.0000165659.20988.25
18. Yinnon AM, Morali GA, Goren A, Rudensky B, Isacsohn M, Michel J, et al. Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel. Isr J Med Sci. 1993;29:11-6. Medline:8454438
19. Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect. 2000;40:59-63. Medline:10762113 doi:10.1053/ jinf.1999.0586
20. Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007;11:52-7. Medline:16651018 doi:10.1016/j.ijid.2005.10.011
21. Shehabi A, Shakir K, el-Khateeb M, Qubain H, Fararjeh N, Shamat AR. Diagnosis and treatment of 106 cases of human brucellosis. J Infect. 1990;20:5-10. Medline:2299182 doi:10.1016/S0163-4453(90)92214-92216
22. Demiroglu YZ, Turunc T, Aliskan H, Colakoglu S, Arslan H. Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases [in Turkish]. Mikrobiyol Bul. 2007;41:517-27. Medline:18173070
23. Tasbakan MI, Yamazhan T, Gökengin D, Arda B, Sertpolat M, Ulusoy S, et al. Brucellosis: a retrospective evaluation. Trop Doct. 2003;33:151-3. Medline:12875250
24. Pourbagher MA, Pourbagher A, Savas L, Turunc T, Demiroglu YZ, Erol I, et al. Clinical pattern and abdominal sonographic findings in 251 cases of brucellosis in southern Turkey. AJR Am J Roentgenol. 2006;187:W191-4. Medline:16861510 doi:10.2214/AJR.05.0241
25. Trujillo IZ, Zavala AN, Caceres JG, Miranda CQ. Brucellosis. Infect Dis Clin North Am. 1994;8:225-41. Medline:8021445
26. Buchanan TM, Faber LC, Feldman RA. Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy. Medicine (Baltimore). 1974;53:403-13. Medline:4215937 doi:10.1097/00005792-197411000-00001
27. Kokoglu OF, Hosoglu S, Geyik MF, Ayaz C, Akalin S, Buyukbese MA, et al. Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey. Trop Doct. 2006;36:49-51. Medline:16483439 doi:10.1258/004947506775598752
28. Gur A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, et al. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J. 2003;44:33-44. Medline:12619173
29. Hizel K, Guzel O, Dizbay M, Karakus R, Senol E, Arman D, et al. Age and duration of disease as factors affecting clinical findings and sacroiliitis in brucellosis. Infection. 2007;35:434-7. Medline:17906836 doi:10.1007/s15010-007- 6361-z
30. Colmenero JD, Reguera JM, Cabrera FP, Cisneros JM, Orjuela DL, Fernandez-Crehuet J. Serology, clinical manifestations and treatment of brucellosis in different age groups. Infection. 1990;18:152-6. Medline:2365466 doi:10.1007/BF01642103
31. Ayatollahi J. Epidemiological, clinical, diagnostic and therapeutic survey of 686 cases of brucellosis. Ann Saudi Med. 2004;24:398-9. Medline:15573860
32. Feiz J, Sabbaghian H. Miralai. Brucellosis due to Brucella melitensis in children. Clin Pediatr. 1978;17:904-7. doi:10.1177/000992287801 701210
33. Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, Fenech FF. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med. 1988;66:39-54. Medline:3051080
34. Pfischner WC Jr, Ishak KG, Neptune EM Jr, Fox SM III, Farid Z, El Din GN. Brucellosis in Egypt; a review of experience with 228 patients. Am J Med. 1957;22:915-929 doi:10.1016/0002-9343(57)90027-X
35. Fallatah SM, Oduloju AJ, Al-Dusari SN, Fakunle YM. Human brucellosis in Northern Saudi Arabia. Saudi Med J. 2005;26:1562-6. Medline:16228056
36. Bikas C, Jelastopulu E, Leotsinidis M, Kondakis X. Epidemiology of human brucellosis in a rural area of north-western Peloponnese in Greece. Eur J Epidemiol. 2003;18:267-74. Medline:12800954 doi:10.1023/A:1023368420840
37. Avdikou I, Maipa V, Alamanos Y. Epidemiology of human brucellosis in a defined area of Northwestern Greece. Epidemiol Infect. 2005;133:905-10. Medline:16181512 doi:10.1017/ S0950268805003973
38. Demirturk N, Demirdal T, Erben N, Demir S, Asci Z, Kilit TP, et al. Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment. Trop Doct. 2008;38:59-62. Medline:18302876 doi:10.1258/td.2006.006266
39. Rivero-Puente A, Maravi Poma E, Garcia Carasusan M, Gamboa J, Perez C, Eguaras J, et al. Brucellosis: study of 222 cases. II. Clinical aspects of acute brucellosis [in Spanish]. Rev Clin Esp. 1982;166:59-63. Medline:7146521
40. Minas M, Minas A, Gourgulianis K, Stournara A. Epidemiological and clinical aspects of human brucellosis in Central Greece. Jpn J Infect Dis. 2007;60:362-6. Medline:18032835
41. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, Causse M, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine. 1996;75:195-211. Medline:8699960 doi:10.1097/00005792- 199607000-00003
42. Sit D, Kadiroglu AK, Kayabasi H, Hosoglu S. Retrospective evaluation of brucellosis cases inhabiting in Mus province [in Turkish]. Mikrobiyol Bul. 2006;40:289-90. Medline:17001861
43. Namiduru M, Gungor K, Dikensoy O, Baydar I, Ekinci E, Karaoglan I, et al. Epidemiological, clinical and laboratory features of brucellosis: a prospective evaluation of 120 adult patients. Int J Clin Pract. 2003;57:20-4. Medline:12587937
44. Aydoslu B, Celik AD, Kuloglu F, Tansel O, Akata F, Tugrul M. Evaluation of brucellosis patients in Trakya University Hospital [in Turkish]. Mikrobiyol Bul. 2006;40:257-63. Medline:17001856
45. Malik GM. A clinical study of brucellosis in adults in the Asir region of southern Saudi Arabia. Am J Trop Med Hyg. 1997;56:375-7. Medline:9158043
46. Gotuzzo E, Seas C, Guerra JG, Carrillo C, Bocanegra TS, Calvo A, et al. Brucellar arthritis: a study of 39 Peruvian families. Ann Rheum Dis. 1987;46:506-9. Medline:3662637 doi:10.1136/ard.46.7.506
47. Samra Y, Shaked Y, Hertz M, Altman G. Brucellosis: difficulties in diagnosis and a report on 38 cases. Infection. 1983;11:310-2. Medline:6668070 doi:10.1007/BF01641353
48. Solera J, Lozano E, Martinez-Alfaro E, Espinosa A, Castillejos ML, Abad L. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis. 1999;29:1440-9. Medline:10585793 doi:10.1086/313524
49. Tabak F, Hakko E, Mete B, Ozaras R, Mert A, Ozturk R. Is familyscreening necessary in brucellosis? Infection. 2008;36:575-7. Medline:19011744 doi:10.1007/s15010-008-7022-6
50. Mantur BG, Amarnath SK. Brucellosis in India -a review. J Biosci. 2008;33:539-47. Medline:19208979 doi:10.1007/s12038-008-0072-1
51. Solera J, Martínez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodriguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infect. 1998;36:85-92. Medline:9515675 doi:10.1016/S0163-4453(98) 93342-4
52. Ariza J, Corredoira J, Pallares R, Viladrich PF, Rufi G, Pujol M, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241-9. Medline:7620005
53. Kunda J, Fitzpatrick J, Kazwala R, French NP, Shirima G, MacMillan A, et al. Health-seeking behavior of human brucellosis cases in rural Tanzania. BMC Public Health. 2007;7:315. Medline:17980046 doi:10.1186/1471-2458-7-315
54. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25:188-202. Medline:17901634 doi:10.4103/0255-0857.34758
55. Zancada Díaz de Entre-Sotos F, Roldan Montaud A, Fernandez Ballesteros A, Jimenez Jimenez FJ, Agulla Budino A. Brucellosis: a clinico-serological study in a rural health area [in Spanish]. Rev Clin Esp. 1992;191:8-12. Medline:1631373
56. Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa K, Kariholu PJ, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. Med Microbiol. 2006;55:897-903. doi:10.1099/ jmm.0.46097-0
57. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991;13:359-72. Medline:1866536
58. Casao MA, Navarro E, Solera J. Evaluation of Brucellacapt for the diagnosis of human brucellosis. J Infect. 2004;49:102-8. Medline:15236916 doi:10.1016/j.jinf.2004.03.004
59. Serra J, Velasco J, Godoy P, Mendoza J. Can the Brucellacapt test be substituted for the Coombs test in the diagnosis of human brucellosis? [in Spanish]. Enferm Infecc Microbiol Clin. 2001;19:202-5. Medline:11446907
60. Solera J. Treatment of human brucellosis. J Med Liban. 2000;48:255-63. Medline:11214198
61. Joint Food and Agriculture Organization (FAO ), World Health Organization (WHO). FAO -WHO expert committee on brucellosis (sixth report). WHO technical report series, no 740. Geneva: World Health Organization; 1986.
62. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4:e317. Medline:18162038 doi:10.1371/journal.pmed.0040317
63. Ranjbar M, Keramat F, Mamani M, Kia AR, Khalilian FO, Hashemi SH, et al. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis. 2007;11:152-6. Medline:16798042 doi:10.1016/ j.ijid.2005.11.007
64. Bayindir Y, Sonmez E, Aladag A, Buyukberber N. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. J Chemother. 2003;15:466-71. Medline:14598939
65. Mantur BG, Akki AS, Mangalgi SS, Patil SV, Gobbur RH, Peerapur BV. Childhood brucellosis -a microbiological, epidemiological and clinical study. J Trop Pediatr. 2004;50:153-7. Medline:15233191 doi:10.1093/tropej/50.3.153
66. al-Eissa YA, Kambal AM, al-Nasser MN, al-Habib SA, al-Fawaz IM, al-Zamil FA. Childhood brucellosis: a study of 102 cases. Pediatr Infect Dis J. 1990;9:74-9. Medline:2314956 doi:10.1097/00006454-199002000-199100002
67. Williams E. The Mediterranean fever commission: its origin and achievements. In: Young EJ, Corbel MJ, editors. Brucellosis: clinical and laboratory aspects. Boca Raton (FL): CRC Press Ink; 1989. p.22.
68. Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. Int J Infect Dis. 2009;13:e339-43. Medline:19428283 doi:10.1016/j.ijid.2009.02.015
69. Dahouk SA, Neubauer H, Hensel A, Schoneberg I, Nockler K, Alpers K, et al. Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg Infect Dis. 2007;13:1895-900. Medline:18258041
70. Onyemelukwe GC. Brucellosis in northern Nigerians. West Afr J Med. 1989;8:234-40. Medline:2486804
71. Colmenero JD, Ruiz-Mesa JD, Plata A, Bermudez P, Martín-Rico P, Queipo-Ortuno MI, et al. Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis. 2008;46:426-33. Medline:18181740 doi:10.1086/525266
72. Reguera JM, Alarcon A, Miralles F, Pachon J, Juarez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis. 2003;22:647-50. Medline:14566576 doi:10.1007/s10096- 003-1026-z
73. Ferreira P, Gama P, Correia J, Nunes L, Pipa J, Nascimento C, et al. Brucella endocarditis -case report and literature review. Rev Port Cardiol. 2008;27:1309-15. Medline:19178031
74. Gunes Y, Tuncer M, Guntekin U, Akdag S, Ali Gumrukcuoglu H, Karahocagil M, et al. Clinical characteristics and outcome of Brucella endocarditis. Trop Doct. 2009;39:85-8. Medline:19299289 doi:10.1258/td.2008.070436
75. Kress S, Klooker P, Kaufmann V, Sloot N, Riemann JF, Brass H. Brucellosis with fatal endotoxic shock [in German]. Med Klin (Munich). 1997;92:561-6. Medline:9411206 doi:10.1007/ BF03044933
76. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis. 1992;15:582-90. Medline:1420670
77. Pandit VR, Seshadri S, Valsalan R, Bahuleyan S, Vandana KE, Kori P. Acute brucellosis complicated by fatal myocarditis. Int J Infect Dis. 2010;14:e358-60. Medline:19665411 doi:10.1016/j.ijid.2009.05.013
78. Park KW, Kim DM, Park CY, Kim HL, Jang SJ, Choi YS, et al. Fatal systemic infection with multifocal liver and lung nodules caused by Brucella abortus. Am J Trop Med Hyg. 2007;77:1120-3. Medline:18165533
79. Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E. Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis. 2000;31:904-9. Medline:11049768 doi:10.1086/318129
80. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly. 2004;134:564-8. Medline:15551160
81. Solera J, Rodríguez-Zapata M, Geijo P, Largo J, Paulino J, Saez L, et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother. 1995;39:2061-7. Medline:8540716
82. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1999;18:535-8. Medline:10517189 doi:10.1007/s100960050344
83. Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]. BMC Infect Dis. 2004;4:18. Medline:15214959 doi:10.1186/1471-2334-4-18
84. Hadadi A, Rasoulinejad M. HajiAbdolbaghi M, Mohraz M, Khashayar P. Clinical profile and management of brucellosis in Tehran -Iran. Acta Clin Belg. 2009;64:11-5. Medline:19317236
85. Ersoy Y, Sonmez E, Tevfik MR, But AD. Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct. 2005;35:210-2. Medline:16354469 doi:10.1258/00494750577 4938765
86. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly. 2004;134:564-8. Medline:15551160
87. Ariza J, Gudiol F, Valverde J, Pallares R, Fernandez-Viladrich P, Rufi G, et al. Brucellar spondylitis: a detailed analysis based on current findings. Rev Infect Dis. 1985;7:656-64. Medline:3903944